(Q35000949)

5 August 2017

1 reference

title

The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin (English)

1 reference

5 August 2017

0 references

1 reference

Charles J Glueck

1

1 reference

5 August 2017

Naila Goldenberg

series ordinal

2

1 reference

5 August 2017

Patricia Streicher

series ordinal

3

1 reference

5 August 2017

Ping Wang

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Expert Opinion on Pharmacotherapy

5 August 2017

1 reference

5 August 2017

3

1 reference

5 August 2017

11

1 reference

5 August 2017

1557-1568

1 reference

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

5 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Clinical outcomes of pregnancy with one elevated glucose tolerance test value

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Perinatal and maternal outcomes of fetal macrosomia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

The prevalence of polycystic ovaries in women with a history of gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

The principles of dietary management of gestational diabetes: reflection on current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

A trial of simple versus intensified dietary modification for prevention of progression to diabetes mellitus in women with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Review of gestational diabetes mellitus and low-calorie diet and physical exercise as therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Effect of a high monounsaturated fatty acid diet on blood pressure and glucose metabolism in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

When and how to start insulin treatment in gestational diabetes: a UK perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Metabolic and immunologic effects of insulin lispro in gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

A comparison of glyburide and insulin in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Oral hypoglycaemic agents in 118 diabetic pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Glyburide and fetal safety; transplacental pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Metformin in management of pregnant insulin-independent diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1557

10.1517/14656566.3.11.1557

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference